Benzodiazepine use not linked to dementia
by Bruce Sylvester: Benzodiazepine therapy in older adults is not associated with an increase in dementia risk, researchers reported on Feb. 2, 2016 in The BMJ today.
by Bruce Sylvester: Benzodiazepine therapy in older adults is not associated with an increase in dementia risk, researchers reported on Feb. 2, 2016 in The BMJ today.
by Gary Finnegan: Researchers have developed a new scoring system that rates women’s risk of Caesarean section. The study combines a range of indicators to help maternity hospitals… read more.
by Gary Finnegan: Good news in the battle against cancer: death rates from leukaemia among people of all ages in Europe are falling.
by Gary Finnegan: Infants that gain weight in their first year of life are more likely to develop type 1 diabetes, according to a study of children born… read more.
by Gary Finnegan: Six new medicines, two of which had been fast-tracked, were given positive reviews from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP)…. read more.
by Gary Finnegan: The European Medicines Agency has released a revised guideline on medicines for the treatment of Alzheimer’s disease and other forms of dementia. The publication is… read more.
by Gary Finnegan: The European Medicines Agency has set up a task force on Zika virus in an effort to accelerate the development of new medicines and vaccines… read more.
by Thomas R. Collins: Standing at the center of a decade and a half of stunning advancements in the treatment of multiple myeloma is the ubiquitin proteasome pathway… read more.
by Bruce Sylvester: Women with heart failure are as likely as men to achieve survival benefit from receiving an implantable cardiac defibrillator, researchers reported on Jan. 12,2016 in Circulation: Heart… read more.
by Thomas R. Collins: Fresh off its approval in the U.S. in the relapsed/refractory setting of multiple myeloma, ixazomib continues to be examined in other patient pools, with… read more.
by Bruce Sylvester: No matter what their blood pressure is at the beginning of treatment, blood pressure-lowering drugs should be offered to all persons at high risk of… read more.
by Gary Finnegan: Ten medicines, including a first-in-class orphan medicine for narcolepsy, were recommended for authorisation in the EU at the latest meeting of the European Medicines Agency’s Committee for Medicinal… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.